Myers Q2 Revenue Surges, Transformation Gains Traction

What happened

Myers reported Q2 2026 revenue growth of 9.8%, fueled by infrastructure and food and beverage demand, alongside improving adjusted margins and earnings as its Focused Transformation program advanced. This result handily beats prior expectations of low-single-digit growth and suggests the Signature/Scepter platform is delivering on its promise, offsetting the drag from the underperforming Distribution segment. The strong quarter validates the cost-cutting and mix-shift strategy, but it does not remove the overhang of the pending Myers Tire Supply sale, which remains a critical catalyst. With trailing P/E still above 27x and leverage elevated, the market is now pricing in more of the turnaround, leaving less room for disappointment. Execution risk remains: sustaining this growth and closing the MTS divestiture on acceptable terms are essential for the thesis to fully mature.

Implication

Myers' strong Q2 results signal that the Focused Transformation is taking hold, likely reducing the probability of the bear case and supporting a more constructive medium-term outlook. However, with the stock already trading at a rich 27x P/E and 13x EV/EBITDA on trailing numbers, much of the good news is priced in, and any stumbles in the MTS sale or a return of end-market softness could quickly deflate the multiple. If management can demonstrate that the 9.8% top-line growth is sustainable and that adjusted margins are on a firm upward trajectory, the bull case becomes much more credible, potentially pushing fair value toward the mid-$20s. The largest single upside catalyst remains a clean sale of Myers Tire Supply, which would unlock significant deleveraging and allow the market to focus on the higher-quality Material Handling business. Until that event occurs, the stock's risk-reward is balanced, making it appropriate to hold at lower cost bases or consider trimming near resistance levels around $22, while waiting for a more attractive entry or clearer de-risking events.

Thesis delta

The Q2 2026 revenue surge and margin improvement shift the thesis from a cautious wait-and-see to a more constructive stance, as the Focused Transformation is clearly bearing fruit. However, the stock still trades at a rich multiple based on trailing earnings, and the Myers Tire Supply sale remains a key unresolved catalyst that could de-risk or disappoint. Consequently, the bear case probability may diminish, but the bull case requires further evidence of sustained high growth and a successful MTS exit.